Sinopharm Group Ltd. Total Current Liabilities

The latest total current liabilities for SHTDF is $260B as of June 2026. That compares with $280B in the prior-year period — down 7.7% year over year. Investors often review this figure alongside Sinopharm Group Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SHTDF's total current liabilities moved from $280B to $260B — a 7.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sinopharm Group Ltd.'s operating scale or balance-sheet position.

A total current liabilities figure of $260B for SHTDF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHTDF's total current liabilities ($260B), review year-over-year change from $280B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.